InsightfulValue
← Home

Daiichi Sankyo
Daiichi Sankyo

-4.06%

Pharma / Pharmaceuticals, Biotechnology


πŸ”§ Tools

βœ… Due Diligence
Company at a Glance

Daiichi Sankyo

πŸ“Š Get full analytics about Daiichi Sankyo

Sign up for free or log in

πŸ’‘ Learn smarter stock picks with "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

Price
Live  
Overview
and its operations
Daiichi Sankyo is a global pharmaceutical company based in Japan. It was founded in 2005 through the merger of two Japanese pharmaceutical companies, Daiichi Pharmaceutical and Sankyo Co., Ltd. The company's global headquarters is located in Tokyo, Japan, and it has several research and development sites in Japan, Germany, and the United States.
Daiichi Sankyo is primarily focused on the development of innovative medicines for the treatment of cardiovascular, metabolic, and infectious diseases, as well as oncology. The company also has a strong presence in the over-the-counter and generic drug markets.
Daiichi Sankyo operates in more than 20 countries worldwide and has a diverse portfolio of drugs marketed in over 60 countries. The company's global sales in the fiscal year 2020 were approximately 950 billion yen (about $8.8 billion USD).
In addition to developing and marketing drugs, Daiichi Sankyo is also actively engaged in research and development collaborations with academic institutions and other pharmaceutical companies. The company's goal is to continue expanding its portfolio and delivering innovative treatment options to patients around the world.
Some of Daiichi Sankyo's notable drugs include:
- LIXIANA (rivaroxaban), an oral anticoagulant used to prevent and treat blood clots
- Thromboreductin (tenecteplase), a clot-dissolving enzyme used to treat heart attacks
- EVISTA (raloxifene), a selective estrogen receptor modulator used to treat osteoporosis and reduce the risk of developing breast cancer
- RECLAST (zoledronic acid), an intravenous medication used to treat osteoporosis and prevent bone fractures
- Benicar (olmesartan medoxomil), a blood pressure medication used to treat hypertension
- Oncology drugs, including ENHERTU (trastuzumab deruxtecan), for the treatment of HER2-positive breast and gastric cancer, and pexidartinib, for the treatment of certain types of tumors.
What is special about the company?
Daiichi Sankyo

πŸ“ˆ Want to read more about Daiichi Sankyo?

Sign up for free or log in

✍️ Sign up to get "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" for free

MS4gUGlvbm VlcmluZyBQ aGFybWFjZX V0aWNhbCBD b21wYW55Oi BEYWlpY2hp IFNhbmt5by BpcyBhIGds b2JhbCBwaG FybWFjZXV0 aWNhbCBjb2 1wYW55IHRo YXQgaGFzIG JlZW4gaW4g b3BlcmF0aW 9uIGZvciBv dmVyIDEwMC B5ZWFycy4g SXQgaGFzIG Egc3Ryb25n IHRyYWNrIH JlY29yZCBv ZiBkZXZlbG 9waW5nIGlu bm92YXRpdm UgbWVkaWNp bmVzIGFuZC B0cmVhdG1l bnRzIGZvci B2YXJpb3Vz IGRpc2Vhc2 VzIGFuZCBj b25kaXRpb2 5zLjxicj4y LiBHbG9iYW wgUHJlc2Vu Y2U6IFRoZS Bjb21wYW55 IGhhcyBhIH N0cm9uZyBp bnRlcm5hdG lvbmFsIHBy ZXNlbmNlLC B3aXRoIG9w ZXJhdGlvbn MgaW4gbW9y ZSB0aGFuID UwIGNvdW50 cmllcyB3b3 JsZHdpZGUu IEl0IGhhcy BhIHdpZGUg bmV0d29yay BvZiByZXNl YXJjaCwgZG V2ZWxvcG1l bnQsIGFuZC BtYW51ZmFj dHVyaW5nIG ZhY2lsaXRp ZXMgaW4gQX NpYSwgRXVy b3BlLCBhbm QgTm9ydGgg QW1lcmljYS 48YnI+My4g Rm9jdXNlZC BvbiBLZXkg VGhlcmFwZX V0aWMgQXJl YXM6IERhaW ljaGkgU2Fu a3lvIGlzIG ZvY3VzZWQg b24gZGV2ZW xvcGluZyB0 cmVhdG1lbn RzIGluIGEg ZmV3IGtleS B0aGVyYXBl dXRpYyBhcm VhcywgbmFt ZWx5IGNhcm Rpb3Zhc2N1 bGFyIGRpc2 Vhc2UsIG9u Y29sb2d5LC BwYWluIG1h bmFnZW1lbn QsIGFuZCBp bW11bmUgZG lzb3JkZXJz LiBUaGlzIG FsbG93cyB0 aGUgY29tcG FueSB0byBj b25jZW50cm F0ZSBpdHMg cmVzb3VyY2 VzIGFuZCBl eHBlcnRpc2 Ugb24gZGV2 ZWxvcGluZy BlZmZlY3Rp dmUgdHJlYX RtZW50cyBp biB0aGVzZS BhcmVhcy48 YnI+NC4gQ2 9tbWl0bWVu dCB0byBSZX NlYXJjaCBh bmQgRGV2ZW xvcG1lbnQ6 IFRoZSBjb2 1wYW55IGlu dmVzdHMgYS BzaWduaWZp Y2FudCBwb3 J0aW9uIG9m IGl0cyByZX ZlbnVlIGlu dG8gcmVzZW FyY2ggYW5k IGRldmVsb3 BtZW50LCB3 aXRoIGEgc3 Ryb25nIGZv Y3VzIG9uIG RldmVsb3Bp bmcgaW5ub3 ZhdGl2ZSB0 cmVhdG1lbn RzLiBUaGlz IGNvbW1pdG 1lbnQgdG8g UiZEIGhhcy BoZWxwZWQg dGhlbSB0by BicmluZyBt YW55IGxpZm Utc2F2aW5n IGFuZCBsaW ZlLWVuaGFu Y2luZyBtZW RpY2luZXMg dG8gcGF0aW VudHMgd29y bGR3aWRlLj xicj41LiBD b2xsYWJvcm F0aXZlIEFw cHJvYWNoOi BEYWlpY2hp IFNhbmt5by BlbWJyYWNl cyBhIGNvbG xhYm9yYXRp dmUgYXBwcm 9hY2ggdG8g cmVzZWFyY2 ggYW5kIGRl dmVsb3BtZW 50LCBwYXJ0 bmVyaW5nIH dpdGggb3Ro ZXIgY29tcG FuaWVzLCBy ZXNlYXJjaC BpbnN0aXR1 dGlvbnMsIG FuZCBhY2Fk ZW1pYyBjZW 50ZXJzIHRv IGJyaW5nIG l0cyBtZWRp Y2luZXMgdG 8gbWFya2V0 LiBUaGlzIG NvbGxhYm9y YXRpb24gaG VscHMgdG8g YWNjZWxlcm F0ZSB0aGUg ZGV2ZWxvcG 1lbnQgb2Yg bmV3IGRydW dzIGFuZCB0 cmVhdG1lbn RzLjxicj42 LiBTdHJvbm cgUGlwZWxp bmU6IFRoZS Bjb21wYW55 IGhhcyBhIH JvYnVzdCBw aXBlbGluZS BvZiBpbm5v dmF0aXZlIG 1lZGljaW5l cyBpbiB2YX Jpb3VzIHN0 YWdlcyBvZi BkZXZlbG9w bWVudCwgcH JvdmlkaW5n IGEgc3Ryb2 5nIGZvdW5k YXRpb24gZm 9yIGZ1dHVy ZSBncm93dG ggYW5kIGV4 cGFuc2lvbi 48YnI+Ny4g Q29ycG9yYX RlIFNvY2lh bCBSZXNwb2 5zaWJpbGl0 eTogRGFpaW NoaSBTYW5r eW8gaXMgY2 9tbWl0dGVk IHRvIGNvcn BvcmF0ZSBz b2NpYWwgcm VzcG9uc2li aWxpdHkgYW 5kIHN1c3Rh aW5hYmlsaX R5LCB3aXRo IGEgZm9jdX Mgb24gZXRo aWNhbCBidX NpbmVzcyBw cmFjdGljZX MsIGVtcGxv eWVlIHdlbG wtYmVpbmcs IGFuZCBzb2 NpYWwgYW5k IGVudmlyb2 5tZW50YWwg aW5pdGlhdG l2ZXMuPGJy PjguIFBhdG llbnQtQ2Vu dGVyZWQgQX Bwcm9hY2g6 IFRoZSBjb2 1wYW55J3Mg bWlzc2lvbi BpcyB0byBz dHJpdmUgZm 9yIHRoZSAi Y3JlYXRpb2 4gb2YgbmV3 IGhlYWx0aG NhcmUgZnJv bnRpZXJzIi B0aHJvdWdo IHRoZSBkZX ZlbG9wbWVu dCBvZiBpbm 5vdmF0aXZl IG1lZGljaW 5lcyB0aGF0 IG1lZXQgdG hlIG5lZWRz IGFuZCBpbX Byb3ZlIHRo ZSBxdWFsaX R5IG9mIGxp ZmUgb2YgcG F0aWVudHMg d29ybGR3aW RlLjxicj45 LiBEaXZlcn NpZmllZCBQ b3J0Zm9saW 86IEluIGFk ZGl0aW9uIH RvIGl0cyBw aGFybWFjZX V0aWNhbCBi dXNpbmVzcy wgRGFpaWNo aSBTYW5reW 8gYWxzbyBo YXMgYSBwcm VzZW5jZSBp biBvdGhlci BoZWFsdGhj YXJlIHNlY3 RvcnMsIGlu Y2x1ZGluZy BvdmVyLXRo ZS1jb3VudG VyIG1lZGlj YXRpb25zLC BtZWRpY2Fs IGRldmljZX MsIGFuZCBk aWFnbm9zdG ljcywgcHJv dmlkaW5nIG EgZGl2ZXJz aWZpZWQgcG 9ydGZvbGlv IG9mIHByb2 R1Y3RzIGFu ZCBzZXJ2aW Nlcy48YnI+ MTAuIFN0cm 9uZyBNYW5h Z2VtZW50IF RlYW06IFRo ZSBjb21wYW 55IGhhcyBh IHN0cm9uZy BhbmQgZXhw ZXJpZW5jZW QgbWFuYWdl bWVudCB0ZW FtIHdpdGgg YSBwcm92ZW 4gdHJhY2sg cmVjb3JkIG 9mIHN1Y2Nl c3MgaW4gdG hlIHBoYXJt YWNldXRpY2 FsIGluZHVz dHJ5LCBlbn N1cmluZyB0 aGUgY29tcG FueSdzIHN0 cm9uZyBwZX Jmb3JtYW5j ZSBhbmQgbG 9uZy10ZXJt IHN1c3RhaW 5hYmlsaXR5 Lg==
What the company's business model?
Daiichi Sankyo

πŸ“ˆ Want to read more about Daiichi Sankyo?

Sign up for free or log in

πŸ™Œ Join now to get "The Checklist Value Investor β€” A Smarter Way to Pick Stocks" at no cost

RGFpaWNoaS BTYW5reW8g aXMgYSBnbG 9iYWwgcGhh cm1hY2V1dG ljYWwgY29t cGFueSB0aG F0IGZvY3Vz ZXMgb24gdG hlIHJlc2Vh cmNoLCBkZX ZlbG9wbWVu dCwgYW5kIG 1hbnVmYWN0 dXJlIG9mIG lubm92YXRp dmUgbWVkaW NpbmVzLiBU aGVpciBidX NpbmVzcyBt b2RlbCByZX ZvbHZlcyBh cm91bmQgZG V2ZWxvcGlu ZyBhbmQgY2 9tbWVyY2lh bGl6aW5nIG 5ldyBhbmQg aW1wcm92ZW QgdHJlYXRt ZW50cyB0by BhZGRyZXNz IHVubWV0IG 1lZGljYWwg bmVlZHMuPG JyPlRoZSBj b21wYW55J3 MgY29yZSBi dXNpbmVzcy BzdHJhdGVn eSBpcyBidW lsdCBvbiB0 aHJlZSBrZX kgcGlsbGFy czogPGJyPj EuIElubm92 YXRpb246IE RhaWljaGkg U2Fua3lvIG ludmVzdHMg aGVhdmlseS BpbiByZXNl YXJjaCBhbm QgZGV2ZWxv cG1lbnQgKF ImRCkgdG8g ZGlzY292ZX IgYW5kIGRl dmVsb3Agbm V3IG1lZGlj aW5lcyBhY3 Jvc3MgYSBy YW5nZSBvZi B0aGVyYXBl dXRpYyBhcm VhcywgaW5j bHVkaW5nIG NhcmRpb3Zh c2N1bGFyLC BvbmNvbG9n eSwgYW5kIH JhcmUgZGlz ZWFzZXMuIF RoZSBjb21w YW55IGhhcy BhIGxhcmdl IGdsb2JhbC BSJkQgbmV0 d29yaywgaW 5jbHVkaW5n IHBhcnRuZX JzaGlwcyBh bmQgY29sbG Fib3JhdGlv bnMgd2l0aC BsZWFkaW5n IHVuaXZlcn NpdGllcyBh bmQgcmVzZW FyY2ggaW5z dGl0dXRpb2 5zLjxicj4y LiBHcm93dG g6IFRoZSBj b21wYW554o CZcyBncm93 dGggc3RyYX RlZ3kgaXMg Y2VudGVyZW Qgb24gZXhw YW5kaW5nIG l0cyBnbG9i YWwgcHJlc2 VuY2UgYW5k IHBvcnRmb2 xpbyB0aHJv dWdoIHN0cm F0ZWdpYyBw YXJ0bmVyc2 hpcHMsIGFs bGlhbmNlcy wgYW5kIGFj cXVpc2l0aW 9ucy4gVGhp cyBhbGxvd3 MgRGFpaWNo aSBTYW5reW 8gdG8gYWNj ZXNzIG5ldy BtYXJrZXRz LCB0ZWNobm 9sb2dpZXMs IGFuZCB0aG VyYXBpZXMs IGFzIHdlbG wgYXMgZGl2 ZXJzaWZ5IG l0cyBwcm9k dWN0IG9mZm VyaW5ncy48 YnI+My4gUm VzcG9uc2li aWxpdHk6IE RhaWljaGkg U2Fua3lvIG hhcyBhIHN0 cm9uZyBjb2 1taXRtZW50 IHRvIGV0aG ljYWwgYW5k IHNvY2lhbG x5IHJlc3Bv bnNpYmxlIG J1c2luZXNz IHByYWN0aW Nlcy4gVGhp cyBpbmNsdW RlcyBjb25k dWN0aW5nIG FsbCBidXNp bmVzcyBhY3 Rpdml0aWVz IHdpdGggaW 50ZWdyaXR5 IGFuZCB0cm Fuc3BhcmVu Y3ksIGFzIH dlbGwgYXMg c3VwcG9ydG luZyBpbml0 aWF0aXZlcy B0byBpbXBy b3ZlIGFjY2 VzcyB0byBo ZWFsdGhjYX JlIGFuZCBh ZGRyZXNzIG dsb2JhbCBo ZWFsdGggY2 hhbGxlbmdl cy48YnI+T3 ZlcmFsbCwg RGFpaWNoaS BTYW5reW8n cyBidXNpbm VzcyBtb2Rl bCBmb2N1c2 VzIG9uIGNv bnRpbnVhbG x5IGludmVz dGluZyBpbi BSJkQgYW5k IHN0cmF0ZW dpYyBncm93 dGggb3Bwb3 J0dW5pdGll cyB0byBkcm l2ZSBpbm5v dmF0aW9uIG FuZCBicmlu ZyBhZHZhbm NlZCBtZWRp Y2luZXMgdG 8gcGF0aWVu dHMgd29ybG R3aWRlLg==
Interesting facts about the company
Daiichi Sankyo

πŸ“ˆ Want to read more about Daiichi Sankyo?

Sign up for free or log in

πŸ“ Join us and grab your copy of "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

CiAgICAgIC AgICAgIDxk aXYgc3R5bG U9J3dpZHRo OiAxMDAlOy BkaXNwbGF5 OiBmbGV4Oy BqdXN0aWZ5 LWNvbnRlbn Q6IGNlbnRl cjsnPgogIC AgICAgICAg ICAgICAgPG RpdiBzdHls ZT0nCiAgIC AgICAgICAg ICAgICAgIC AgZGlzcGxh eTogZmxleD sKICAgICAg ICAgICAgIC AgICAgICBh bGlnbi1pdG VtczogY2Vu dGVyOwogIC AgICAgICAg ICAgICAgIC AgIGJhY2tn cm91bmQtY2 9sb3I6ICNm MGY0Zjg7Ci AgICAgICAg ICAgICAgIC AgICAgYm9y ZGVyOiAxcH ggc29saWQg I2QxZTNmMD sKICAgICAg ICAgICAgIC AgICAgICBi b3JkZXItcm FkaXVzOiAx MHB4OwogIC AgICAgICAg ICAgICAgIC AgIHBhZGRp bmc6IDEwcH g7CiAgICAg ICAgICAgIC AgICAgICAg bWFyZ2luOi AyMHB4IDA7 CiAgICAgIC AgICAgICAg ICAgICAgZm 9udC1mYW1p bHk6ICJTZW dvZSBVSSIs IFJvYm90by wgc2Fucy1z ZXJpZjsKIC AgICAgICAg ICAgICAgIC AgICBib3gt c2hhZG93Oi AwIDJweCA2 cHggcmdiYS gwLCAwLCAw LCAwLjA1KT sKICAgICAg ICAgICAgIC AgICAgICBt YXgtd2lkdG g6IDkwMHB4 OwogICAgIC AgICAgICAg ICAgICAgIH dpZHRoOiAx MDAlOyc+Cg ogICAgICAg ICAgICAgIC AgICAgIDxp bWcgc3JjPS Jhc3NldHMv bG9nb3MvZk pCNEZmczRM QUU1cG1TQ2 pkZ3Mud2Vi cCIgYWx0PS JEYWlpY2hp IFNhbmt5by IgdGl0bGU9 IkRhaWljaG kgU2Fua3lv IiAgY2xhc3 M9ImltZy1m bHVpZCIgaG VpZ2h0PTkw IHdpZHRoPT kwIGxvYWRp bmc9J2xhen knIHN0eWxl PSdib3JkZX ItcmFkaXVz OiA2cHg7Jz 4KCiAgICAg ICAgICAgIC AgICAgICAg PGRpdiBzdH lsZT0nZmxl eDogMTsgdG V4dC1hbGln bjogY2VudG VyOyBtYXJn aW4tbGVmdD ogNXB4Oyc+ CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDxwIHN0 eWxlPSdmb2 50LXNpemU6 IDI2cHg7IG NvbG9yOiAj MzMzOyBtYX JnaW4tYm90 dG9tOiAxNX B4Oyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICDwn5OI IFdhbnQgdG 8gcmVhZCBt b3JlIGFib3 V0IERhaWlj aGkgU2Fua3 lvPwogICAg ICAgICAgIC AgICAgICAg ICAgICA8L3 A+CgogICAg ICAgICAgIC AgICAgICAg ICAgICA8YS BocmVmPSdp bmRleC5waH A/cGFnZT1z aWdudXAnIH N0eWxlPScK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGJh Y2tncm91bm QtY29sb3I6 ICMwMDdCRk Y7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bjb2xvcjog I2ZmZjsKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIHBhZG Rpbmc6IDEw cHggMjBweD sKICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIG JvcmRlci1y YWRpdXM6ID VweDsKICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgIHRleHQt ZGVjb3JhdG lvbjogbm9u ZTsKICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg IGZvbnQtd2 VpZ2h0OiBi b2xkOwogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgbWFyZ2 luLXJpZ2h0 OiAxMHB4Ow ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgdH JhbnNpdGlv bjogYmFja2 dyb3VuZC1j b2xvciAwLj NzIGVhc2U7 JwogICAgIC AgICAgICAg ICAgICAgIC AgICAgICAg b25tb3VzZW 92ZXI9J3Ro aXMuc3R5bG UuYmFja2dy b3VuZENvbG 9yPSIjMDA1 NmIzIicKIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgIG9ubW 91c2VvdXQ9 J3RoaXMuc3 R5bGUuYmFj a2dyb3VuZE NvbG9yPSIj MDA3QkZGIi c+CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC BTaWduIHVw IGZvciBmcm VlCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDwvYT 4KCiAgICAg ICAgICAgIC AgICAgICAg ICAgIDxzcG FuIHN0eWxl PSdtYXJnaW 46IDAgOHB4 OyBjb2xvcj ogIzU1NTsn Pm9yPC9zcG FuPgoKICAg ICAgICAgIC AgICAgICAg ICAgICAgPG EgaHJlZj0n aW5kZXgucG hwP3BhZ2U9 bG9naW4nIH N0eWxlPScK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIGNv bG9yOiAjMD A3QkZGOwog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgdGV4 dC1kZWNvcm F0aW9uOiB1 bmRlcmxpbm U7CiAgICAg ICAgICAgIC AgICAgICAg ICAgICAgIC Bmb250LXdl aWdodDogNT AwOyc+CiAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgICBsb2cg aW4KICAgIC AgICAgICAg ICAgICAgIC AgICAgPC9h PgoKCiAgIC AgICAgICAg ICAgICAgIC AgICAgIDxw IHN0eWxlPS dtYXJnaW4t dG9wOiAxNX B4OyBmb250 LXNpemU6ID EzcHg7IGZv bnQtd2VpZ2 h0OiBib2xk OyBjb2xvcj ogI2QzMmYy ZjsnPgogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAg8J+ZjC BKb2luIG5v dyB0byBnZX QgPGk+IlRo ZSBDaGVja2 xpc3QgVmFs dWUgSW52ZX N0b3Ig4oCU IEEgU21hcn RlciBXYXkg dG8gUGljay BTdG9ja3Mi PC9pPiBhdC BubyBjb3N0 CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwvcD4K CiAgICAgIC AgICAgICAg ICAgICAgIC AgIDwhLS0K ICAgICAgIC AgICAgICAg ICAgICAgIC AgPGRpdiBz dHlsZT0nbW FyZ2luLXRv cDogMTJweD sgZm9udC1z aXplOiAxM3 B4OyBjb2xv cjogIzQ0ND snPgogICAg ICAgICAgIC AgICAgICAg ICAgICAgIC AgU2lnbiB1 cCBub3cgYW 5kIGdldCBv dXIgZnJlZS BlQm9vayAK ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgIDxi PlRoZSBDaG Vja2xpc3Qg VmFsdWUgSW 52ZXN0b3Ig 4oCUIEEgU2 1hcnRlciBX YXkgdG8gUG ljayBTdG9j a3M8L2I+Ci AgICAgICAg ICAgICAgIC AgICAgICAg IDwvZGl2Pg ogICAgICAg ICAgICAgIC AgICAgICAg ICAtLT4KIC AgICAgICAg ICAgICAgIC AgICAgICAg PCEtLQogIC AgICAgICAg ICAgICAgIC AgICAgICA8 ZGl2IHN0eW xlPSdtYXJn aW4tdG9wOi AxNnB4OyBm b250LXNpem U6IDE0cHg7 IGNvbG9yOi AjNDQ0OyBm b250LWZhbW lseTogLWFw cGxlLXN5c3 RlbSwgQmxp bmtNYWNTeX N0ZW1Gb250 LCBTZWdvZS BVSSwgUm9i b3RvLCBIZW x2ZXRpY2Eg TmV1ZSwgc2 Fucy1zZXJp ZjsgbGluZS 1oZWlnaHQ6 IDEuNjsnPg ogICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgSG F2ZSB5b3Ug aGVhcmQgYW JvdXQgb3Vy IHNob3J0ID xzdHJvbmcg c3R5bGU9J2 ZvbnQtd2Vp Z2h0OiA2MD A7Jz5EYWls eSBWaWRlby BOZXdzbGV0 dGVyPC9zdH Jvbmc+Pwog ICAgICAgIC AgICAgICAg ICAgICAgIC AgICAgPGEg aHJlZj0naH R0cHM6Ly93 d3cuaW5zaW dodGZ1bHZh bHVlLmNvbS 9uZXdzbGV0 dGVyLnBocC cgdGFyZ2V0 PSdfYmxhbm snIHN0eWxl PSdjb2xvcj ogIzAwN0JG RjsgdGV4dC 1kZWNvcmF0 aW9uOiBub2 5lOyBmb250 LXdlaWdodD ogNTAwOyBt YXJnaW4tbG VmdDogNnB4 Oyc+CiAgIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgICAgRm luZCBvdXQg bW9yZQogIC AgICAgICAg ICAgICAgIC AgICAgICAg ICAgPC9hPg ogICAgICAg ICAgICAgIC AgICAgICAg ICA8L2Rpdj 4KICAgICAg ICAgICAgIC AgICAgICAg ICAgLS0+Ci AgICAgICAg ICAgICAgIC AgICAgPC9k aXY+CiAgIC AgICAgICAg ICAgICA8L2 Rpdj4KICAg ICAgICAgIC AgPC9kaXY+ CiAgICAgIC AgICAgIAog ICAgICAgIA ogICAgICAg IDxzcGFuIG NsYXNzPSdi bHVycmVkLX RleHQnPgog ICAgICAgIC AgICBNUzRn UkdGcGFXIE 5vYVNCVFlX NXIgZVc4Z1 EyOXRjRyBG dWVTd2dUR2 x0IGFYUmxa Q0JwY3kgQm hJR2RzYjJK aCBiQ0J3YU dGeWJXIEZq WlhWMGFXTm ggYkNCamIy MXdZVyA1NU lIZHBkR2dn IGFYUnpJR2 hsWVcgUnhk V0Z5ZEdWeS BjeUJzYjJO aGRHIFZrSU dsdUlGUnYg YTNsdkxDQk tZWCBCaGJp NGdTWFFnIG QyRnpJR1p2 ZFcgNWtaV1 FnYVc0ZyBN akF3TlNCMG FIIEp2ZFdk b0lIUm8gWl NCdFpYSm5a WCBJZ2IyWW dkSGR2IElF cGhjR0Z1Wl ggTmxJSEJv WVhKdCBZV0 5sZFhScFky IEZzSUdOdm JYQmggYm1s bGN5d2dSRy BGcGFXTm9h U0JRIGFHRn liV0ZqWlgg VjBhV05oYk NCaCBibVFn VTJGdWEzIG x2SUVOdkxp d2cgVEhSa0 xqeGljaiA0 eUxpQlVhR1 VnIGJtRnRa U0JFWVcgbH BZMmhwSUZO aCBibXQ1Yn lCMGNtIEZ1 YzJ4aGRHVn ogSUhSdklI Um9aUyBCbW FYSnpkQ0Iw IGFISmxaU0 IyYVggSjBk V1Z6SUdsdS BJRVZ1WjJ4 cGMyIGdzSU hkb2FXTm8g SUhONWJXSn ZiRyBsNlpY TWdkR2hsIE lHTnZiWEJo Ym4gbmlnSm x6SUdOdiBi VzFwZEcxbG JuIFFnZEc4 Z1oyOXYgWk NCb1pXRnNk RyBnc0lHbH VibTkyIFlY UnBkbVVnYV cgUmxZWE1z SUdGdSBaQ0 J6YjJOcFlX IHdnWTI5dW MyTnAgYjNW emJtVnpjeS A0OFluSStN eTRnIFJHRn BhV05vYVMg QlRZVzVyZV c4ZyBhR0Z6 SUdFZ1pHIG wyWlhKelpT QncgYjNKMF ptOXNhVyA4 Z2IyWWdjSE psIGMyTnlh WEIwYVcgOX VJRzFsWkds aiBhVzVsY3 l3Z1ptIDlq ZFhOcGJtY2 cgYjI0Z1lY SmxZWCBNZ2 MzVmphQ0Jo IGN5QmpZWE prYVcgOTJZ WE5qZFd4aC BjaXdnYjI1 amIyIHh2Wj Nrc0lHRnUg WkNCd1lXbH VJRyAxaGJt Rm5aVzFsIG JuUXVJRlJv Wlgga2dZWE psSUdGcyBj MjhnYVc1Mm IyIHgyWldR Z2FXNGcgZE dobElHUmxk bSBWc2IzQn RaVzUwIElH OW1JSFpoWT IgTnBibVZ6 SUdGdSBaQ0 JpYVc5c2Iy IGRwWTNNdV BHSnkgUGpR dUlFUmhhVy BsamFHa2dV MkZ1IGEzbH ZJR2hoY3kg QmhJSE4wY2 05dSBaeUJ3 Y21WelpXID VqWlNCcGJp QkIgYzJsaE xDQjNhWCBS b0lHOTJaWE lnIE1qWWxJ RzltSUcgbD BjeUJ6WVd4 bCBjeUJqYj IxcGJtIGNn Wm5KdmJTQj AgYUdseklI SmxaMiBsdm JpNGdTWFFn IFlXeHpieU JvWVggTWdi M0JsY21GMC BhVzl1Y3lC cGJpIEJPYj NKMGFDQkIg YldWeWFXTm hMQyBCRmRY SnZjR1VzIE lHRnVaQ0J2 ZEcgaGxjaU J3WVhKMCBj eUJ2WmlCMG FHIFVnZDI5 eWJHUXUgUE dKeVBqVXVJ RSBsdUlESX dNRFlzIElF UmhhV2xqYU cga2dVMkZ1 YTNsdiBJR0 ZqY1hWcGNt IFZrSUdFZ2 JXRnEgYjNK cGRIa2djMy BSaGEyVWdL RFkwIEpTa2 dhVzRnU1cg NWthV0Z1SU dkbCBibVZ5 YVdNZ2NHIG hoY20xaFky VjEgZEdsal lXd2dZMiA5 dGNHRnVlU0 JTIFlXNWlZ WGg1SUUgeG hZbTl5WVhS diBjbWxsY3 k0Z1ZHIGhs SUdGamNYVn AgYzJsMGFX OXVJRyBGc2 JHOTNaV1Fn IFJHRnBhV0 5vYVMgQlRZ VzVyZVc4Zy BkRzhnWlho d1lXIDVrSU dsMGN5Qnkg WldGamFDQn BiaSBCbGJX VnlaMmx1IF p5QnRZWEpy WlggUnpMan hpY2o0MiBM aUJVYUdVZ1 kyIDl0Y0dG dWVTQnAgY3 lCamIyMXRh WCBSMFpXUW dkRzhnIGMz VnpkR0ZwYm 0gRmlhV3hw ZEhrZyBZVz VrSUdoaGN5 IEJwYlhCc1 pXMWwgYm5S bFpDQjJZWC BKcGIzVnpJ R2x1IGFYUn BZWFJwZG0g VnpJSFJ2SU hKbCBaSFZq WlNCcGRIIE 1nWlc1MmFY SnYgYm0xbG JuUmhiQyBC cGJYQmhZM1 FzIElITjFZ MmdnWVggTW djbVZrZFdO cCBibWNnWT JGeVltIDl1 SUdWdGFYTn ogYVc5dWN5 QmhibSBRZ2 NISnZiVzkw IGFXNW5JR2 R5WlcgVnVJ SEJ5YjJOMS BjbVZ0Wlc1 MExqIHhpY2 o0M0xpQkUg WVdscFkyaH BJRiBOaGJt dDVieUJvIF lYTWdZU0J6 ZEggSnZibW NnWm05aiBk WE1nYjI0Z2 NtIFZ6WldG eVkyZ2cgWV c1a0lHUmxk bSBWc2IzQn RaVzUwIElD aFNKa1FwTE MgQjNhWFJv SUc5MiBaWE lnWVNCeGRX IEZ5ZEdWeU lHOW0gSUds MGN5QmxiWC BCc2IzbGxa WE1nIFpHVm thV05oZEcg VmtJSFJ2SU hSbyBhWE1n WVhKbFlTID RnVkdobGVT Qm8gWVhabE lGSW1SQyBC bVlXTnBiR2 wwIGFXVnpJ R2x1SUUgcG hjR0Z1TENC SCBaWEp0WV c1NUxDIEJo Ym1RZ2RHaG wgSUZWdWFY UmxaQyBCVG RHRjBaWE1z IElHRnRiMj VuSUcgOTBh R1Z5SUdOdi BkVzUwY21s bGN5IDQ4WW 5JK09DNGcg U1c0Z01qQX hNeSB3Z1JH RnBhV05vIG FTQlRZVzVy ZVcgOGdjbV ZqWldsMiBa V1FnWVhCd2 NtIDkyWVd3 Z1ptOXkgSU dsMGN5Qm1h WCBKemRDQm hiblJwIFlt OWtlUzFrY2 4gVm5JR052 Ym1wMSBaMk YwWlNBb1FV IFJES1NCd2 NtOWsgZFdO MExDQjNhRy BsamFDQmpi MjFpIGFXNW xjeUJoYmkg QmhiblJwWW 05ayBlU0Jo Ym1RZ1lTIE JqYUdWdGIz Um8gWlhKaG NIa2daSCBK MVp5QjBieU IwIFlYSm5a WFJsWkMgQm pZVzVqWlhJ ZyBZMlZzYk hNZ1lXIDVr SUcxcGJtbH QgYVhwbElH UmhiVyBGbl pTQjBieUJv IFpXRnNkR2 g1SUcgTmxi R3h6TGp4aS BjajQ1TGlC VWFHIFVnWT I5dGNHRnUg ZVNCb1lYTW dZUyBCemRI SnZibWNnIF kyOXRiV2ww YlcgVnVkQ0 IwYnlCdyBh R2xzWVc1MG FIIEp2Y0hr Z1lXNWsgSU doaGN5Qnpa WCBRZ2RYQW dkR2hsIElF UmhhV2xqYU cga2dVMkZ1 YTNsdiBJRV p2ZFc1a1lY IFJwYjI0Z2 IyWWcgVEds bVpTQlRZMi BsbGJtTmxJ SFJ2IElITj FjSEJ2Y24g UWdjbVZ6Wl dGeSBZMmdn WVc1a0lHIF ZrZFdOaGRH bHYgYmlCcG JpQjBhRyBV Z2JHbG1aU0 J6IFkybGxi bU5sY3kgQm 1hV1ZzWkM0 OCBZbkkrTV RBdUlFIEZ6 SUc5bUlESX cgTWpFc0lF UmhhVyBsam FHa2dVMkZ1 IGEzbHZJR2 hoWkMgQnZk bVZ5SURFMi BMREF3TUNC bGJYIEJzYj NsbFpYTWcg ZDI5eWJHUj NhVyBSbElH RnVaQ0JuIF pXNWxjbUYw WlcgUWdiM1 psY2lBayBP Q0JpYVd4c2 FXIDl1SUds dUlISmwgZG 1WdWRXVXVJ RSBsMElHbH pJSEpoIGJt dGxaQ0JoYl cgOXVaeUIw YUdVZyBkRz l3SURJd0lI IEJvWVhKdF lXTmwgZFhS cFkyRnNJRy BOdmJYQmhi bWxsIGN5Qm 5iRzlpWVcg eHNlUzQ9Ci AgICAgICAg PC9zcGFuPg ogICAgICAg IAogICAgIC AgIA==
See Company Q&A
Daiichi Sankyo

πŸ“Š Get full analytics about Daiichi Sankyo

Sign up for free or log in

πŸ“˜ Claim your free eBook: "The Checklist Value Investor β€” A Smarter Way to Pick Stocks"

© 2024 - 2026 InsightfulValue.com. All rights reserved. Newsletter
Legal